Rakuten Securities Inc. Takes $78,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Rakuten Securities Inc. acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,006 shares of the company’s stock, valued at approximately $78,000.

A number of other large investors have also recently bought and sold shares of GEHC. Pin Oak Investment Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $25,000. Resources Management Corp CT ADV bought a new stake in GE HealthCare Technologies in the second quarter valued at $28,000. First Command Advisory Services Inc. boosted its holdings in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares during the period. Fortitude Family Office LLC bought a new stake in GE HealthCare Technologies in the 4th quarter valued at about $29,000. Finally, Householder Group Estate & Retirement Specialist LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.8 %

Shares of NASDAQ:GEHC opened at $85.19 on Thursday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a market capitalization of $38.87 billion, a price-to-earnings ratio of 28.21, a PEG ratio of 2.99 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a 50 day moving average price of $88.61 and a 200 day moving average price of $77.65.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Argus raised their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Mizuho lifted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $95.08.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.